Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2

Szu Ting Chen, Simmy Thomas, Kevin J. Gaffney, Stan G. Louie, Nicos A. Petasis, Axel H. Schönthal

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Inhibition of cyclooxygenase 2 (COX-2) by the selective COX-2 inhibitor celecoxib has been suggested as potentially useful for B-cell lymphoma therapy. However, additional pharmacological activities of celecoxib have been discovered and have challenged the notion that its antitumor effects are mediated primarily via the inhibition of COX-2. To shed light on this issue, we have investigated the effects of different pharmacological agents with greatly varying COX-2 inhibitory potency in Raji lymphoma cells in vitro. We found that cytotoxic potency of these compounds did not at all correlate with their COX-2 inhibitory activity; in fact, the most potent COX-2 inhibitors lacked the ability to kill Raji cells. Instead, the cytotoxic outcome was closely aligned with these agents' ability to trigger endoplasmic reticulum (ER) stress, which could be further enhanced by bortezomib, an agent with known ER stress-inducing potency. Together, these results indicate that celecoxib's cytotoxic effects on Raji lymphoma cells do not involve the inhibition of COX-2.

Original languageEnglish (US)
Pages (from-to)250-253
Number of pages4
JournalLeukemia Research
Volume34
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

Keywords

  • CHOP/GADD153
  • Cyclooxygenase-2
  • Endoplasmic reticulum stress

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2'. Together they form a unique fingerprint.

Cite this